Acknowledgment
- PDF / 60,883 Bytes
- 1 Pages / 612.28 x 790.87 pts Page_size
- 61 Downloads / 188 Views
Mol Diagn Ther 2011; 15 (6): 311 1177-1062/11/0006-0311/$49.95/0
ª 2011 Adis Data Information BV. All rights reserved.
Dear Reader, As we reach the final issue of Molecular Diagnosis & Therapy for 2011, we hope that you have found the articles published throughout the year to be both interesting and informative. The editors and publishing staff have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date with topical issues in diagnostics and personalized medicine in 2012. The high quality of Adis Journals was further recognized in the new ISI impact factors (IFs) for 2010, with the majority of our titles making strong IF gains over 2009. The most impressive gains were made by Sports Medicine (IF 5.072), with a 63% increase making it the highest-ranked title in its field, and PharmacoEconomics (IF 3.44), increasing by 34% to become the leading health outcomes research journal. Drugs in R&D (IF 1.707), re-launched in 2010 as Adis’ first fully openaccess MEDLINE-indexed journal, increased its IF by 26%. Other stand-out performers include CNS Drugs (IF 4.497) and BioDrugs (IF 4.192), with increases of 16% and 20%, respectively. Another significant milestone was reached by The Patient: Patient-Centered Outcomes Research, with the journal achieving MEDLINE indexing this year. The Patient was launched by Adis in 2008 as the first journal dedicated to the needs, values, and role of patients in healthcare decision making. Last, but not least, we would like to say a big thank you to all of the authors who have contributed articles to Molecular Diagnosis & Therapy in the last 12 months. Without their hard work and diligence, we would not have been able to publish the journal. The quality of published articles reflects also the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals, who acted as referees for articles in Molecular Diagnosis & Therapy in 2011: Heidi Albert, Uganda Rachel Ballard-Barbash, USA Niaz Banaei, USA Ritu Banerjee, USA Vickie E. Baracos, Canada Ivan Brukner, Canada Andrew Buckton, UK Mengli Cai, USA Peter T. Campbell, USA John Carlquist, USA Subhankar Chakraborty, USA Zhiwei Chen, Hong Kong Itay Chowers, Israel Elizabeth Dax, Australia Richard F. de Boer, the Netherlands Sarah E. Flanagan, UK Elisa Giovanetti, the Netherlands Peisong Goa, USA Jens K. Habermann, Germany Danielle A.M. Heideman, the Netherlands Mirjam H.A. Hermans, the Netherlands Victor Huber, USA Daniel L. Jacoby, USA Ozgur Kemik, Turkey Gilbert J. Kersh, USA Thomas Klimkait, Switzerland Tuckweng Kok, Australia Yrjo T. Konttinen, Finland Reijo Laaksonen, Finland Hsien-Yuan Lane, Taiwan Tracey G. Lively, USA Lukasz A. Malek, Poland Chester A. Mathis, USA John W. McCauley, UK Donald C. McMillan, UK Akira Moh, USA
Jason H. Moore, USA Alison Motsinger-Reif, USA Kimberlee A. Musser, U
Data Loading...
